Literature DB >> 19838512

Parkinsonism and AIDS: a clinical comparative study before and after HAART.

Ana Lucia Zuma de Rosso1, James Pitágoras de Mattos, Rosalie Branco Correa, Denise Hack Nicaretta, Sérgio Augusto Pereira Novis.   

Abstract

In 2002, after analyzing 28 HIV-positive patients with movement disorders we emphasized the decreasing not only of Parkinsonism but also of other involuntary movements in HIV patients in the last few years. The objective of this study is to compare the clinical results between HIV-positive patients with Parkinsonism before and after HAART. In 14 years (1986-1999) 2,460 HIV-positive patients were seen in our Hospital 14 (0.6%) of which presented with Parkinsonism. Eight years after (2000-2007) 970 HIV positive patients were seen and only two (0.2%) had Parkinsonism. We conclude that after the introduction of HAART there was an evident decrease in AIDS-related Parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19838512     DOI: 10.1590/s0004-282x2009000500009

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  7 in total

1.  Reversible progressive supranuclear palsy-like phenotype as an initial manifestation of HIV infection.

Authors:  Wooyoung Jang; Joong-Seok Kim; Jin Young Ahn; Hee-Tae Kim
Journal:  Neurol Sci       Date:  2011-12-09       Impact factor: 3.307

2.  Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice.

Authors:  Katherine E Olson; Aditya N Bade; Krista L Namminga; Mary Jane Potash; R Lee Mosley; Larisa Y Poluektova; David J Volsky; Howard E Gendelman
Journal:  J Neurovirol       Date:  2018-03-28       Impact factor: 2.643

Review 3.  Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Authors:  Elyse J Singer; April D Thames
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

4.  Parkinsonian Syndrome and Toxoplasmic Encephalitis.

Authors:  Anca-Adriana Arbune; Manuela Arbune; Victorita Stefanescu
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-05-09

Review 5.  The Role of Pathogens and Anti-Infective Agents in Parkinson's Disease, from Etiology to Therapeutic Implications.

Authors:  Si Shen; Chan Zhang; Yu-Ming Xu; Chang-He Shi
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

Review 6.  Viruses, parkinsonism and Parkinson's disease: the past, present and future.

Authors:  Valentina Leta; Daniele Urso; Lucia Batzu; Yue Hui Lau; Donna Mathew; Iro Boura; Vanessa Raeder; Cristian Falup-Pecurariu; Daniel van Wamelen; K Ray Chaudhuri
Journal:  J Neural Transm (Vienna)       Date:  2022-08-29       Impact factor: 3.850

7.  Does antiretroviral therapy alter the course of Parkinson's disease in people living with HIV?

Authors:  Ferzana Hassan Amod; Ahmed Iqbal Bhigjee; Anand Moodley
Journal:  J Neurovirol       Date:  2021-08-05       Impact factor: 2.643

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.